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Abstract
Introduction: Primary intestinal lymphangiectasia is a disorder characterized by exudative enteropathy resulting
from morphologic abnormalities of the intestinal lymphatics. Intestinal lymphangiectasia can be primary or
secondary, so the diagnosis of primary intestinal lymphangiectasia must first exclude the possibility of secondary
intestinal lymphangiectasia. A double-balloon enteroscopy and biopsy, as well as the pathology can be used to
confirm the diagnosis of intestinal lymphangiectasia. A polymeric diet containing medium-chain triglycerides and
total parenteral nutrition may be a useful therapy.
Case presentation: A 17-year-old girl of Mongoloid ethnicity was admitted to our hospital with a history of
diarrhea and edema. She was diagnosed with protein-losing enteropathy caused by intestinal lymphangiectasia.
This was confirmed by a double-balloon enteroscopy and multi-dot biopsy. After treatment with total parenteral
nutrition in hospital, which was followed by a low-fat and medium-chain triglyceride diet at home, she was totally
relieved of her symptoms.
Conclusion: Intestinal lymphangiectasia can be diagnosed with a double-balloon enteroscopy and multi-dot
biopsy, as well as the pathology of small intestinal tissue showing edema of the submucosa and lymphangiectasia.
Because intestinal lymphangiectasia can be primary or secondary, the diagnosis of primary intestinal
lymphangiectasia must first exclude the possibility of secondary intestinal lymphangiectasia. A positive clinical
response to the special diet therapy, namely a low-fat and medium-chain triglyceride diet, can further confirm the
diagnosis of primary intestinal lymphangiectasia.
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Introduction
Primary intestinal lymphangiectasia (PIL), also named
Waldmann’s disease, is a rare disorder characterized by ex-
udative enteropathy resulting from morphologic abnormal-
ities of the intestinal lymphatics [1]. Edema (moderate to
severe with pleural effusion, pericarditis, or chylous ascites)
is the main clinical manifestation but lymphedema, fatigue,
abdominal pain, weight loss, moderate diarrhea, and fat-
soluble vitamin deficiencies may also be present [1].
Patients can also develop hypocalcemia secondary to failure
to absorb fat and fat-soluble vitamins.
It is difficult to confirm the diagnosis of PIL using sero-
logical tests, endoscopy, colonoscopy and normal image
check, but the diagnosis can be established by double-
balloon enteroscopy, multi-dot biopsy, and especially by the
pathologic examination of small intestinal tissue showing
edema of the submucosa and lymphangiectasia. Intestinal
lymphangiectasia (IL) can be primary or secondary so the
diagnosis of PIL must first exclude the possibility of second-
ary IL. Tests that exclude proteinuria and rheumatic, neo-
plastic and parasitic infection can be used to exclude the
possibility of secondary IL.
Patients who have been discharged with an improve-
ment in hypoproteinemia may prevent recurrent enteric
protein loss by using total parenteral nutrition (TPN) and
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medium-chain triglycerides (MCTs). The need for fat re-
striction has been described as permanent due to the fre-
quent clinical relapses upon relaxation of the regimen. It
is considered that, when treating out-patients with IL, en-
teral nutrition should be continued as long as hypoprotei-
nemia is present [2,3]. In more severe cases, the use of
octreotide, a synthetic analogue of the naturally occurring
hormone somatostatin (a potent inhibitor of the release of
growth hormone, serotonin, gastrin, glucagon and insu-
lin), has been found to be successful [4].
Here, we present a case of PIL that was diagnosed by
double-balloon enteroscopy and multi-biopsy, and had a
positive response to TPN and MCTs.
Case presentation
A 17-year-old girl of Mongoloid ethnicity presented to
our hospital with a history of diarrhea and edema in her
eyelids and lower limbs for three weeks, which were sec-
ondary to a transient fever lasting one week. About one
month prior to this admission, the patient complained
of a fever (the highest temperature being 39°C) accom-
panied by sore throat, cough, and runny nose, but no
fear of cold or shivering. These symptoms lasted for
about one week and disappeared. Then the diarrhea and
edema in her eyelids and lower limbs began. The fre-
quency of stools was about two to three times a day.
The stools were like yellow water with a little foam, and
contained undigested foods. The patient also complained
of poor appetite, occasional abdominal distention and
abdominal pain. Her food intake was reduced to be-
tween one-third and half of her usual amount. She usu-
ally had gruel and did not like meat. She lost two kg in
this one month. She denied hair loss, rash, skin ery-
thema, oral ulcers, photosensitivity, joints pain, foamy
urine, palpitations, night sweats, headache, chest pain,
paroxysmal nocturnal dyspnea, insomnia, irritability, and
tremor. There was nothing of significance in her medical
history or drug therapy.
Her physical examination demonstrated malnutrition
and edema in her eyelids and lower limbs. A few lymph
nodes of 0.5×0.5cm in size were found in her submandibu-
lar area, in her axillas and inguina on both sides, with clear
borders and no tenderness. Her body mass index was
15kg/m2. Her heart rate was 120 beats per minute and
other systematic examinations revealed no positive signs.
She was admitted to the Rheumatology department of
our hospital at first. Investigations showed decreased
white blood cells (2.71×109/L; neutrophils 1.64×109/L,
lymphocytes 0.34×109/L), anemia (hemoglobin 100g/L),
hypoalbuminemia (serum albumin 20.5g/L), hypoimmu-
noglobulinemia (globulin 12g/L), hypolipoproteinemia
(cholesterol 2.8mmol/L; triglyceride 0.28mmol/L), and
hypocalcemia (1.52mmol/L). During her hospital stay,
the patient had numbness and convulsions in both
hands several times and these symptoms were relieved
by calcium and vitamin D therapy. The results of a
Coombs’ test and anticardiolipin antibodies were both
negative. Results of tests related to Sjögren’s syndrome,
systemic lupus erythematosus, rheumatoid arthritis, and
vasculitis were almost normal. The results of the investi-
gation indicated that rheumatologic disease could be
ruled out.
Further investigations showed mildly increased free
triiodothyronine, anti-thyroid-stimulating hormone
receptor antibody, parathyroid hormone, phosphorus,
and decreased thyroid-stimulating hormone in serum.
Emission computed tomography showed a diffuse goi-
ter, and an increased thyroid technetium uptake func-
tion. Ultrasound showed ascites of 32.6mm in depth.
The patient was transferred to the Department of
endocrinology.
The patient had paroxysmal paralysis in her palms
many times. The attacks were always accompanied by
the hyperextension of her fingers. Each attack lasted a
few minutes. The symptoms could be relieved by the
intravenous injection of calcium gluconate. The ser-
ium calcium levels fluctuated in the range of 1.33 to
1.52mmol/L. After the patient was given calcium and
vitamin D supplementation, the symptoms stopped.
Her 24-hour urinary protein excretion and lymphangi-
ography were both normal. The Epstein–Barr virus
and hepatitis virus were not detected in her serum. An
electronic gastroscope revealed superficial antral gas-
tritis. Capsule endoscopy showed that villi edema were
present in the small intestinal (descending part of the
duodenum and upper jejunum part of duodenum) mu-
cosa. So at last she was transferred to the Department
of gastroenterology.
A double-balloon enteroscopy revealed lymphan-
giectasia-like changes in the small intestinal mucosa
(descending part of the duodenum and upper jejunum
part of duodenum; Figure 1A, 1B). The pathologic
analysis of small intestinal tissue showed chronic in-
flammation, edema in the submucosa, and lymphan-
giectasia (Figure 1C).
Based on these findings, a therapy composed of albu-
min and calcium supplementation and parenteral nutri-
tion support was given to the patient. The patient
undertook recipes that strictly conformed to the low-fat
and MCT diet. The daily intake of cooking oil on MCTs
was 25 g and the total fat intake must not exceed 40g/day.
After 10 weeks of dietary treatment, the patient’s clin-
ical manifestations and nutritional status were improved.
The patient no longer felt any discomfort in her daily life
and work. Results of the laboratory examination con-
ducted after the 10-week diet therapy are shown in
Table 1. A repeat double-balloon enteroscopy showed
that the lymphangiectasia-like change in the small
Lai et al. Journal of Medical Case Reports 2013, 7:19 Page 2 of 5
http://www.jmedicalcasereports.com/content/7/1/19
intestines had vanished. The double-balloon enteroscopy
results are shown in Figure 1D and 1E, and the path-
ology is shown in Figure 1F.
Discussion
IL is a relatively rare disorder that manifests itself
through intestinal malabsorption. Its worldwide inci-
dence and prevalence is unknown. The disease affects
males and females equally, and there is no racial predi-
lection. The disease can be primary (congenital), where
there is malformation within the lymphatic channels
leading to their blockage, and the condition is usually
diagnosed within the first decade of life. The condition
can also be secondary to other disease states, such as
constrictive pericarditis, lymphoma, sarcoidosis and
scleroderma, and it can affect older adults. The first
manifestations are usually persistent diarrhea and per-
ipheral edema. The edema can be unilateral or bilateral,
and macular edema revealed in funduscopic examin-
ation has been reported (blindness caused by this is re-
versible). Common symptoms of IL are steatorrhoea,
lymphocytopenia, hypogammaglobulinemia, hypopro-
teinemia, and malabsorption [5]. The mechanisms for
enteric protein loss in IL are not well understood,
although an increase in the pressure of the lymph
channels has been suggested to be a possible cause of
protein loss [2,3].
A jejunal biopsy usually establishes a definitive diagno-
sis, and displays dilation of mucosal and submucosal
lymphatic channels without any evidence of inflamma-
tion. The lymphatic hypoplasia results in an obstruction
in lymph flow, which leads to increased pressure within
the lymphatics. This, in turn, will cause dilation of the
lymphatic channels in the intestine and, finally, lead to
the rupture of the channels and resultant discharge of
the lymph into the lumen of the bowel [5]. The charac-
teristic endoscopic and radiographic features of IL have
been documented thereby greatly facilitating an accurate
diagnosis [6,7].
In this case, the first presentation was found to be
hypoproteinemia. After excluding synthetic obstacles
and insufficient intake as the causes, we concluded that
protein loss was the main factor. We also repeated some
tests to exclude proteinuria. At last, we were sure that it
was a protein-losing gastrointestinal disease. Thus we
carried out a gastroscopy, colonoscopy and capsule en-
doscopy to locate the lesion, and used a double-balloon
Figure 1 A double-balloon enteroscopy and pathologic investigation were performed before and after 10-week treatment.
A and B: The double-balloon enteroscopy revealed lymphangiectasia-like changes in the small intestinal mucosa. C: The pathologic analysis of
small intestinal tissue before treatment showed chronic inflammation, edema in the submucosa, and lymphangiectasia (hematoxylin and eosin
stain×200). D and E: The lymphangiectasia-like changes in the small intestinal mucosa vanished after diet therapy. F: The pathologic results after
treatment were improved (hematoxylin and eosin stain×200).
Table 1 Results of the laboratory examination conducted
before and after the 10-week diet therapy
Laboratory
examination
Pre-treatment After the 10-week diet
therapy
White blood cell 2.71×109/L 4.02×109/L
neutrophils 1.64×109/L 2.56×109/L
lymphocytes 0.34×109/L 1.08×109/L
Hemoglobin 100 g/L 110 g/L
Serum albumin 20.5 g/L 32.5 g/L
Serum globulin 12 g/L 22 g/L
Serum calcium 1.52 mmol/L 2.05 mmol/L
Serum cholesterol 2.8 mmol/L 5.1 mmol/L
Serum triglyceride 0.28 mmol/L 1.00 mmol/L
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endoscope to perform the biopsy in the lesion of IL,
based on some tests that excluded rheumatic, neoplastic,
and parasitic infection. The diagnosis of PIL was
established.
Enteral nutrition, as well as TPN, may be a useful
therapy in patients with IL. Once the serum protein
level has returned to normal, continuation of enteral
nutrition appears to be valuable in preventing relapse.
Compared with TPN, the elemental diet and the poly-
meric diet, which contains MCTs, are ideal mainten-
ance therapies because they are safer, inexpensive, and
more convenient to prepare at home [8]. The main
clinical manifestation of this case was severe malnutri-
tion and, following this, the appearance of hypoprotei-
nemia, hypocalcemia, and hypothyroxinemia. However,
the complaint of diarrhea was not as serious. Based on
these findings, a therapy composed of albumin and cal-
cium supplementation and parenteral nutrition support
was given to the patient.
In this case TPN was used at first so that the patient
could recover quickly from hypothyroxinemia, hypocal-
cemia, and hypoproteinemia. However, TPN is an incon-
venient therapy, so we chose enteral nutrition which
contains a low-fat diet and a MCT diet. There has been
no specific therapy for this condition, although it is
known that fat restriction can successfully reduce gastro-
intestinal protein loss in most patients with IL. Surgery
may be successful when fibrotic changes of the small
bowel cause partial mechanical bowel obstruction [9].
Antiplasmin therapy has been applied to patients who
respond poorly to other therapies [10]. Alternatively,
octreotide has been documented to improve protein-
losing enteropathy in IL by speculative mechanisms
including reduction in lymph flow and immunomodula-
tory action [11,12]. When patients do not respond to a
fat-restricted diet, these medical therapies should be
considered.
Because a partial block of the intestinal lymphatic sys-
tem produces a loss of lymph into the lumen upon a
high-fat diet, dietary fat restriction is considered to be
the first choice of treatment in IL [2,13,14]. In practice,
reduction of the intestinal lymph flow through fat re-
striction has been reported [2,3]. Likewise, a diet con-
taining MCTs as a substitute for long-chain triglycerides
is of benefit because MCTs are absorbed directly into
the portal vein, rather than the lymphatics, thereby redu-
cing the pressure of the lymph channels [15].
We preferred to choose the special diet as the first
therapy. The patient then undertook recipes that strictly
conformed to the low-fat and MCT diet. After 10 weeks,
the results shown in a repeat laboratory examination
were normal (Table 1). Results from other laboratory
examinations were almost normal. The patient gained
weight, and the main complaints disappeared.
Conclusion
In conclusion, we presented a case in which PIL was
suspected which involved edema associated with protein
loss. Because IL can be primary or secondary, we first
excluded the possibility of secondary IL via tests for
rheumatic, neoplastic, and parasitic infection. Then we
carried out a capsule endoscopy and double-balloon en-
doscopy-assisted biopsy. The pathologic analysis of small
intestinal tissue showing edema in the submucosa and
lymphangiectasia confirmed the diagnosis of IL. The
diagnosis of PIL was finally established after excluding
the secondary pathogeny. A positive clinical response to
the special diet therapy of low-fat and MCTs further
confirmed the diagnosis of PIL.
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